Certification Course in Clinical Research, ICH-GCP, E6 (R3),

Explore the key processes in the clinical study, including informed consent, protocol development, risk based quality management, regulatory submissions, site initiation, safety monitoring, data management, and auditing.

Learn the key stakeholders in a clinical study and their core responsibilities, from protocol compliance and informed consent to safety monitoring, data integrity, and sponsor oversight.

Explore ICH GCP, the international standard for clinical research, outlining its four core objectives—participant protection, data credibility, resource efficiency, and regulatory acceptance—rooted in the Nuremberg Code and Declaration of Helsinki.

Define good clinical practice as an international ethical and scientific standard that protects participants, ensures data integrity, and yields reliable, verifiable results across global trials.

Guard participant safety through rigorous ethics and ongoing monitoring. Ensure credibility, accuracy, and integrity of clinical trial data through standardized procedures and quality assurance.

Explore the 11 fundamental principles of ICH GCP E6 (R3), from ethics and informed consent to quality by design and good manufacturing practice, guiding ethical and scientifically sound clinical trials.

Learn how planning the study and ethical approval safeguard participant safety and rights by preparing the protocol, informed consent forms, risk–benefit assessments, and submitting to the IRB for approval.

Explore the ICH GCP guidelines, an ethical and scientific standard for clinical trials that protect participant rights, safety, and well-being while ensuring credible, reliable data.

Explore the origins and core principles of the Nuremberg Code, emphasizing voluntary informed consent, ethical review, and the shift from forced experimentation to voluntary participation in modern clinical research ethics.

Explore the historical roots of clinical research, from the Nuremberg Code to Helsinki, Kefauver amendments, and Belmont Report, emphasizing informed consent, risk-benefit balance, and ethical review.

Explore the Declaration of Helsinki, its historical context from the Nuremberg trials to modern ethical standards, and how its principles protect participants' rights, safety, and well-being in clinical research.

Trace the evolution of ICH GCP guidelines from E6-R1 to E6-R3, highlighting participant protection, data integrity, and the shift to technology-driven, patient-centered trials.

Safeguard health, rights, and well-being of human subjects in medical research under the general principles of the Declaration of Helsinki.

Trace the tuskegee syphilis study (1932-1972) by the U.S. Public Health Service, involving 600 African American men, and its role in shaping the Belmont Report and informed consent.

Explore how ICH GCP r3 replaces 13 r2 principles with 11 broader principles, emphasizing proportionality, participant-centric trials, and technology-driven data governance for modern clinical research.

Identify the core GCP elements: IRB/independent ethical committee, investigator, sponsor, clinical trial protocol, amendments, and investigator brochure. Explain their roles in protecting participant safety and ensuring ethical oversight.

Explore how ICH guidelines divide drug development into four topics—quality, safety, efficacy, and multidisciplinary—and harmonize standards across Japan, Europe, and the US, including Q-series, S-series, M-series, and GCP.

Learn how IRB/IEC safeguard participant rights and safety, review protocols and informed consent, and monitor trials. See how sponsors, investigators, and data governance ensure regulatory compliance and data integrity.

Understand the investigator brochure as the safety information containing non-clinical and clinical data, adverse events, and dose details, updated by sponsors to guide safety monitoring and informed consent under GCP.

Define the investigator's roles under ICH GCP E6 R3, including qualifications, resources, delegation and supervision, protocol adherence, safety reporting, informed consent, investigational product management, randomization and unblinding, and data integrity.

Investigators and sponsors manage data responsibly across the full trial life cycle under ICH E6 R3, ensuring data governance, confidentiality, audit trails, and traceability for accurate, secure, and reliable reporting.